Xian-2017-Use of Intravenous Recombinant Tissu Copy.pdf (494.54 kB)

Use of Intravenous Recombinant Tissue Plasminogen activator in Patients With Acute Ischemic Stroke Who Take Non–Vitamin K Antagonist Oral Anticoagulants Before Stroke

Download (494.54 kB)
preprint
posted on 07.05.2019 by Ying Xian
This study represents the largest clinical experience of stroke thrombolysis in patients receiving NOACs before stroke. rt-PA appears to be reasonably well tolerated without prohibitive risks for adverse events among selected NOAC-treated patients. However, our observations must be considered as preliminary because of the absence of coagulation parameters, timing of the last NOAC intake, and whether nonspecific reversal strategies may have been applied.

History

Grant ID

13CRP14410024

Licence

Exports

Logo branding

Licence

Exports